Axogen (AXGN) Deferred Taxes (2016 - 2017)
Axogen's (AXGN) quarterly Deferred Taxes came in at -$29051.0 in Q4 2017, down 345.05% year-on-year from $11855.0 in Q4 2016, and down 449.17% quarter-over-quarter from -$5290.0 in Q3 2017.
Axogen (AXGN) Deferred Taxes (2016 - 2017) Analysis & Trends
Axogen's Deferred Taxes history runs 2 years deep, the most recent figure standing at -$29051.0 for Q4 2017.
- On a quarterly basis, Deferred Taxes fell 345.05% year-over-year to -$29051.0 in Q4 2017; TTM through Dec 2017 was -$20443.0, a N/A change from a year earlier, with the FY2017 full-year figure at $70316.0, up 299.93% from the prior year.
- Deferred Taxes fell to -$29051.0 in Q4 2017 per AXGN's latest filing, from -$5290.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $11855.0 in Q4 2016 and bottomed at -$29051.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -29,051.00 |
| Sep 30, 2017 | -5,290.00 |
| Dec 31, 2016 | 11,855.00 |
| Sep 30, 2016 | 2,043.00 |